{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:31:48Z","timestamp":1780378308309,"version":"3.54.1"},"reference-count":41,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Primary cutaneous CD30<jats:sup>+<\/jats:sup> lymphoproliferative disorders are the second most common group of cutaneous T\u2010cell lymphomas (CTCL) and include lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T\u2010cell lymphoma (cALCL). Both disease entities share overlapping clinical, histopathological, and molecular features, thus representing a spectrum of cutaneous CD30<jats:sup>+<\/jats:sup> lymphoproliferative disorders. LyP may be distinguished from cALCL by clinicopathological correlation. In some patients, both diseases may coexist at initial diagnosis or develop over the course of the disease. Mycosis fungoides (MF), the most common CTCL, is not considered a primary cutaneous CD30<jats:sup>+<\/jats:sup> lymphoproliferative disorder, but may occur in some LyP patients. In addition, LyP\u2010like lesions may develop in MF patients. However, this is frequently a manifestation of MF rather than a representation of two different disease entities. Caution also has to be taken in the setting of transformed MF with lesions expressing CD30, as they may be mistaken for either LyP or cALCL, resulting in an inadequate therapeutic approach.<\/jats:p>","DOI":"10.1111\/ddg.13117","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T13:35:44Z","timestamp":1470836144000},"page":"767-782","source":"Crossref","is-referenced-by-count":12,"title":["Primary cutaneous CD30<sup>+<\/sup> lymphoproliferative disorders"],"prefix":"10.1111","volume":"14","author":[{"given":"Iris","family":"Wieser","sequence":"first","affiliation":[{"name":"Department of Dermatology The University of Texas, MD Anderson Cancer Center  Houston Texas U.S.A."},{"name":"Department of Dermatology Paracelsus Medical University  Salzburg Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Translational and Molecular Pathology The University of Texas, MD Anderson Cancer Center  Houston Texas U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Torres Cabala","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Dermatology The University of Texas, MD Anderson Cancer Center  Houston Texas U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[{"name":"Department of Dermatology The University of Texas, MD Anderson Cancer Center  Houston Texas U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3653"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351346"},{"key":"e_1_2_14_4_1","first-page":"3768","article-title":"WHO\u2010EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze R","year":"2009","journal-title":"Hematology"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.11.010"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.013"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1112"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.07.012"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-011-0096-8"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-8-955"},{"key":"e_1_2_14_11_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"A continuing self\u2010healing eruption, clinically benign\u2010histologically malignant","volume":"97","author":"Macaulay WL.","year":"1968","journal-title":"Arch Dermatol"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.4.441"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e75356"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182648596"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.12.952"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1145"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318282d01e"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.5.1678.1678"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2014.02.001"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327480701400205"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318275d1a2"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.12.008"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0192-6"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.001"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13920"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.3787"},{"key":"e_1_2_14_27_1","first-page":"574","article-title":"Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options","volume":"24","author":"Querfeld C","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02484-8"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.74"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054601"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2007.00778.x"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e3182a5683a"},{"issue":"1","key":"e_1_2_14_33_1","first-page":"50","article-title":"ALK\u2010positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases","volume":"98","author":"Oschlies I","year":"2013","journal-title":"A report from the ALCL99 study. Haematologica"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"e_1_2_14_35_1","first-page":"1158","article-title":"Current management of primary cutaneous CD30+ T\u2010cell lymphoproliferative disorders","volume":"23","author":"Kadin ME.","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2345"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.7911"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0736-8046.2004.21500.x"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13061"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.3.306"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.057"},{"key":"e_1_2_14_42_1","first-page":"1309","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides","volume":"132","author":"Kim YH","year":"1996","journal-title":"A long\u2010term outcome analysis. Arch Dermatol"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.13117","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.13117","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.13117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T02:39:39Z","timestamp":1696387179000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.13117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1111\/ddg.13117"],"URL":"https:\/\/doi.org\/10.1111\/ddg.13117","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}